|
1. Tsai ZT and Liaw SL. 1985. The use and the effect of
Ganoderma, Taichung, pp.116-117.
2. Zang M and Su CH. 1990. Ganoderma comphoratum, a new taxon
in genus Ganoderma From Taiwan, China. Acta Botanical
Yunnanical 12, 395-396.
3. Chang, T. T. and Chou, W. N. 1995. Antrodia cinnamomea sp.
nov. on Cinnamomum
4. 陳勁初、林文鑫、陳清農、許勝傑、黃仕政、陳炎鍊. 2001. 台灣特
有真菌-樟芝菌絲體之開發. Fung. Sci. 16: 7-22
5. 張東柱. 1997. 牛樟之病害. 牛樟生物學及育林技術研討會論文集.
林業叢刊 第72號:127-131.
6. 許勝傑、陳清農、陳勁初. 2000. 樟芝宿主專一性之探討. 台灣農業
化學與食品科學 38: 533-539.
7. 黃鈴娟. 2000. 樟芝與姬松茸之抗氧化性質及其多醣組成分析. 國立
中興大學 食品科學系
8. Chang, H. L., Chao, G. R., Chen, C. C. and Mau, J. L. 2001.
Non-volatile taste components of Agaricus blazei, Antrodia
camphorata and Cordyceps militaris mycelia. Food Chem. 74:
203-207.
9. Hirotani, M. and Furuya, T. 1990. Changes of the
triterpenoid patterns during formation of the fruit body in
Ganoderma. Phytochem. 29: 3767-37711.
10.Su, C. H., Yang, Y. Z., Ho, H. O., Hu, C. H. and Sheu, M.
T. 2001. High- performance liquid chromatographic analysis
for the characterization of triterpenoids from Ganoderma.
J. Chromato. Sci. 39: 93-100
11.Kim, H. W. and Kim, B. K. 1999. Biomedicinal Triterpenoids
of Ganoderma lucidum (Curt.: Fr.) P. Karst.
(Aphyllophoromycetideae). Inter. J. Med. Mushrooms 1: 121- 138.
12.Toth, J. O., Luu, B. and Ourisson, G. 1983. Cytotoxic
triterpenes from Ganoderma lucidum. Tetrahedron Lett. 24:
1081-1084.
13.Gan, K. H., Fann, Y. F., Hsu, S. H., Kuo, K. W. and Lin,
C. N. 1998. Mediation of the cytotoxicity of lanostanoids
and steroids of Ganoderma tsugae through apoptosis and cell
cycle. J. Nat. Prod. 61: 485-487.
14.Wang, S. Y., Hsu, M. L., Hsu, H. C., Tzeng, C. H., Lee, S.
S., Shiao, M. S. and Ho, C. K. 1997. The anti-tumor effect
of Ganoderma lucidum is mediated by cytokines released from
activated macrophages. Int. J. Cancer 70: 699-705.
15.Kohda, H., Tokumoto, W., Sakamoto, K., Fujii, M., Hirai,
Y., Yamasaki, K., Komoda, Y., Nakamura, H., Ishihara, S.
and Uchida, M. 1985. The biologically active constituents
of Ganoderma lucidum (FR.) KARST. Histamine release-
inhibitory Triterpenes. Chem. Pharm. Bull. 33: 1367-1374.
16.Chen, D. H., Shiou, W. Y., Wang, K. C., Huang, S. Y., Shie,
Y. T., Tsai, C. M., Shie, J. F. and Chen, K. D. 1999.
Chemotaxonomy of triterpenoid pattern of HPLC of Ganoderma
lucidum and Ganoderma tsugae. J. Chinese Chem. Soc. 46: 47-
51.
17.Cherng, I. H. and Chiang, H. C. 1995. Three new
triterpenoids from Antrodia cinnamomea. J. Natural Products
58: 365-371.
18.Cherng, I. H., Wu, D. P., and Chiang, H. C. 1996.
Triterpenoids from Antrodia cinnamomea. Phytochemistry 41:
263-267.
19.吳德鵬. 1995a. 樟芝微量成分的研究. 國立台灣師範大學化學研究
所碩士論文.
20.簡秋源、姜宏哲、陳淑貞. 1997. 牛樟菇培養性狀及其三類成分分
析之研究，牛樟生物學及育林技術研討會論文集. 林業叢刊第72號：
133-137.
21.Chen, C. H. and Yang, S. W. 1995. New steroid acids from
Antrodia cinnamomea a fungal parasite of Cinnamomum
micranthum. J. Natural Products 58: 1655-1661.
22.Sone, Y., Okuda, R., Wada, N., Kishida, E. and Misaki, A.
1985. Structures and antitumor activaties of the
polysaccharides isolated from fruiting body and the growing
culture of mycelium of Ganoderma lucidum. Agric. Biol.
Chem. 49: 2641-53.
23.Wang, G., Zhang, J., Mizuno, T., Zhuang, C., Ito, H.,
Mayuzumi, H., Okamoto, H. and Li, J. 1993. Antitumor active
polysaccharides from the Chinese mushroom Songshan Lingzhi,
the fruiting body of Ganoderma tsugae. Biosci. Biotech.
Biochem. 57: 894-900.
24.Wasser, S. P. and Weis, A. L. 1999a. Medicinal properties
of substances occurring in higher basidomycetes mushrooms:
current perspectives (review). Intern. J. Med. Mushrooms.
1:31-62.
25.Wasser, S. P. and Weis, A. L. 1999b. Therapeutic effects of
substances occurring in higher basidiomycetes mushrooms: a
modern perspective. Critical ReviewsTM in Immunology. 19:
65-96.
26.Wang, S. Y., Hsu, M. L., Hsu, H. C., Tzeng, C. H., Lee, S.
S., Shiao, M. S. and Ho, C. K. 1997. The anti-tumor effect
of Ganoderma lucidum is mediated by cytokines released from
activated macrophages. Int. J. Cancer 70: 699-705.
27.Eo, S. K., Kim, Y. S., Lee, C. K. and Han, S. S. 1999.
Antiherpetic activities of various protein bound
polysaccharide isolated from Ganoderma lucidum. J
Ethnopharma. 72: 475-481.
28.Mizuno, T. 1999. The extraction and development of
antitumor-active polysaccharides from medicinal mushrooms
in Japan (Review). Inter. J. Med. Mushrooms. 1: 9-29.
29.Lee, I. H., Huang, R. L., Chen, C. T., Chen, H. C., Hsu, W.
C. and Lu, M. K. 2002a. Antrodia camphorate polysaccharides
exhibit anti-hepatitis B virus effects. FEMS Microbiol.
Letters 209: 63-67.
30.王伯徹、陳啟楨、華傑. 1998. 食藥用菇類的培養與應用. 食品工業
發展研究所. p.144-150.
31.蔡雁暉. 2002. 樟芝深層培養液及其多醣體之抗氧化特性. 國立中興
大學 食品科學系研究
32.江素瑛、吳焜裕、王秋萍、魏逸傑、施睿宏、高尚德、謝慶良.
2002. 樟芝之致基因毒性與抗基因毒性評估. 台灣保健食品協會 第
二屆第二次年會 大會議程及論文摘要. p.48.
33.郭淑卿. 2002. 樟芝發酵液對大鼠肝臟纖維化及胃腸功能之改善作
用. 中國醫藥大學 中國藥學研究所藥學碩士論文.
34.林文鑫、陳俊憲、陳勁初、呂鋒州. 2000. 樟芝液態發酵萃取物對腫
瘤細胞株之毒殺性分析. 中華民國食品科學技術學會 第三十次(第十
五屆第二次)會員大會手冊 p. 254.
35.江素瑛. 2001. 靈芝與樟芝之安全與毒理. 「保健食品」跨部會整合
推動委員會 p. 64-72.
36.沈立言. 2000. 牛樟芝菌絲體發酵萃取液對肝臟生理機能性之影響.
89年度保健食品研究開發計畫心得發表會 p.191-198.
37.Huang, L. C., Huang S. J., Chen C. C. and Mau J. L. 1999.
Antioxidant properties of Antrodia camphorata. Proceedings
of 3rd International Conference on Mushroom Biology &
Mushroom Products. p275-283.
38.Hseu, Y. C., Chang, W. C., Hseu, Y. T., Lee, C. Y. Yech, Y.
J., Chen, P. C., Chen, J. Y. and Yang, H. L. 2002.
Protection of oxidative damage by aqueous extract from
Antrodia camphorata mycelia in normal human erythrocytes.
Life Sci. 71: 469-482.
39.劉翠玲. 2002. 樟芝對倉鼠體內脂質代謝與抗氧化狀態之影響. 輔仁
大學 食品營養學系碩士論文.
40.戴宇昀. 2001. 樟芝菌絲體與子實體對四氯化碳及酒精誘導之慢性及
急性肝損傷之保肝功能評估. 國立中興大學 食品科學系研究所碩士
論文.
41.李炫璋、莊正宏、蔡金川、黃仕政、陳勁初、胡淼琳. 2002. 中華民
國食品科學技術學會. 第三十二次(第十六屆第二次)會員大會手冊
p. 339.
42.陳怡欣. 2002. 牛樟芝發酵過濾液對大白鼠肝臟生理機能之影響. 中
國醫藥學院 營養研究所碩士論文.
43.陳秀雯、陳清農、黃仕政、許勝傑、曾虹萍、洪鳴遠、傅麒玲、陳勁
初. 2002. 樟芝菌絲體之免疫調節功能評估. 中華民國食品科學技術
學會. 第三十二次(第十六屆第二次)會員大會手冊 p. 326
44.賴宏亮、呂美津、陳武元、莊64.秀琪. 2002 . 樟芝免疫調節活性之
研究. 台灣保健食品學會. 第二屆第二次年會. 大會議程及壁報論文
摘要. p. 49.
45.張中姿、陳俊憲、林文鑫、陳勁初、呂鋒洲. 2001. 中華民國食品科
學技術學會. 第三十二次(第十六屆第一次)會員大會手冊 p. 265.
46.呂鋒洲. 2002. 牛樟芝各抗腫瘤有效成分的分離、純化，誘發腫瘤凋
亡及其作用機轉的研究. 九十一年度保健食品研究開發計畫成果發表
會. p.13-16.
47.林文川. 2001. 樟芝之藥理學研究. 九十年度保健食品研究開發計畫
成果摘要. p.55-57.
48.Marrack, P. Kappler J. 1990. The staphylococcal
enterotoxins and their relatives. Science 248:705-711.
49.Rietschel, E. T., Kirikae, T., Schade, F.U., Mamat, U.,
Schmidt, G., Loppnow, H., Ulmer, A. J., Zahringer, U.,
Seydel, U., and Padova, F. D. 1994. Bacterial endotxin:
molecular relationships of structure to activity and
function. FASEB J. 8:217-225.
50.Myokai, F., Takashiba, S., Lebo, R., and Amar, S. 1999. A
novel lipopolysaccharide-induced transcription factor
regulating tumor necrosis factor α gene expression:
Molecular cloning, sequencing, characterization, and
chromosomal assignment. Proc. Natl. Acad. Sci. USA. 96:4518-
4523.
51.Kim, D. W. Sovak, M. A., Zanieski, G., Romieu-Mourez, R.,
Lau, A. W., Hafer, L. J., Yaswen, P., Stampfer, M., Rogers,
A. E. 2000. Activation of NF-κB/Rel occurs early during
neoplastic transformation of mammary cells. Carcinogenesis
21: 871-879.
52.Yamaoka, S., Courtois, G., Bessia, C. 1998. Complementation
Cloning of NEMO, a component of the IκB kinase complex
essential for NF-κB activation. Cell 93: 1231-1240.
53.Karin, M. 1999. The beginning of the end: IκB kinase(IKK)
and NF-κB activation. J.Biol. Chem. 274:27339-27343.
54.Barnes, P. J., and Karin, M. 1997. Nuclear factor —κB-A
pivotal transcription factor in chronic inflammatory
diseases. N. Engl. J. Med. 336:1066-1071.
55.Baeuerle, P. A., and Baltimore, D. 1996. NF-κB: Ten years
after. Cell 87:13-20.
56.Romieu-Mourez, R., Landesman-Bollag, E., Seldin, D. C.,
Traish, A. 2001. Roles of IKK kinases and protein kinase
CK2 in activation of nuclear factor-κB in breast cancer.
Cancer Res. 61: 3810-3818.
57.Suh, N., Honda T., Finlay, H. J. 1998. Novel triterpenoids
suppress inducible nitric oxide synthase(iNOS) and
inducible cyclooxygenase(COX-2) in mouse macrophages.
Cancer Res. 58:717-723.
58.Musial, A., and Eissa, N. T. 2001. Inducible nitric-oxide
synthase is regulated by the proteasome degradation
pathway. J. Biol. Chem. 276:24268-24273.
59.Vodovotz, Y., Lucia, M. S. 1996. Inducible nitric oxide
synthase in tangle-bearing neurons of patients with
Alzheimer’s disease. J. Exp. Med. 184:1425-1433.
60.Eissa, N.T., Yuan, J.W., Haggerty, C.M. 1998. Cloning and
characterization of human inducible nitric oxide synthase
splice variants: A doman, encoded by exons 8 and 9, is
critical for dimerization. Proc. Natl. Acad. Sci. USA 95:
7625-7630.
61.Ohshima, H., and Bartsch, H. 1994. Chronic infections and
inflammatory processes as cancer risk factors: possible
role of nitric oxide in carcinogenesis. Mutat. Res. 305:
253-264.
62.Hwang, D., Jang, B. C., Yu, G. 1997. Expression of mitogen-
inducible cyclooxygenase induced by lipopolysaccharide.
Biochem.Pharmacol. 54: 87-96.
63.Ben-Av, P., Crofford, L. J., Wilder, R. L. 1995. Induction
of vascular endothelial growth factor expression in
synovial fibroblasta by prostaglandin E and interleukin-1:
a potential mechanism for inflammatory angiogenesis. FEBS
Letters 372:83-87.
64.Subbaramaiah, K., Zakim, D., Weksler, B. B. 1997.
Inhibition of cyclooxygenase: a novel approach to cancer
prevention. Proc. Soc. Exp. Biol. Med. 216:201-210.
65.Sheng, H., Shao, J., Morrow, J. D. 1998. Modulation of
apoptosis and Bcl-2 expression by prostaglandin E2 in human
colon cancer cells. Cancer Res. 58: 362-366.
66.Sambrook J, Fritttsch EF, Maniatis T. 1989. Molecular
Cloning: A Laboratory Manuuual, 2nd ed. Cold Spring Harbor,
NY, Cold Spring Harbor Laboratory.
67.Gree LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS,
and Tamnnenbaum SR. 1982. Analysis of nitrate and [15N]
nitrate in biological fluids. Analytical Biochemistry. 126:
131-138.
68.Weinstein, S. L., Sanghera, J. S., Lemke, K. 1992.
Bacterial lipopolysaccharide induces tyrosine
phosphorylation and activation of mitogen-activated protein
kinases in macrophages. J. Biol. Chem. 276: 14955-14962.
69.Neary, J. T. 1997. MAPK cascades in cell growth and death.
News Physiol. Sci. 12:286-293.
70.Wu, Y., Brouet, I., Calmels, S. 1993. Increased
endogeneous N-nitrosamine and nitrate formation by
induction of nitric oxide synthase in rats with acute
hepatic injury caused by propionibacterium acnes and
lipopolysaccharide administration. Carcinogenesis 14:7-10. 71.Tamir, S., Tannenbaum, S. R. 1996. The role of nitric oxide
in the carcinogenic process. Biochim. Biophys. Acta 1288:
F31-F36.
72.Kroncke, K. D., Fehsel, K. Nitric oxide: cytotoxicity
versus cytoprotection-How, Why, When, and Where ? Nitric
oxide 1 : 107-120, 1997.
73.Eissa, N. T., Strauss, A. J., Haggerty, C. M.
1996 .Alternative splicing of human inducible nitric-oxide
synthase mRNA. J. Biol. Chem. 271:27184-27187.
74.Dixit, V. D., and Parvixi, N. 2001. Nitric oxide and the
control of reproduction. Anim. Reprod. Sci. 65: 1-16 .
75.Song TY and Yen GC. 2002. Antioxidant properties of
Antrodia camphorata in submerged culture. J Agr Food Chem
50,3322-3327.
76.Yang LL and Chen YC. 2000. Oroxylin A inhibition of
lipopolysaccharide-induced iNOS and COX-2 gene expression
via suppression of nuclear factor-κB activation. 59: 1445-
1457.
77.Wu SH, Ryvarden L, and Chang TT. 1997. Antrodia cinnamomea
(“niu-chang-chih”), New combination of a medicinal fungus
in Taiwan. Bot Bull Acad Sinica 38, 273-275.
78.Kaufman SN. 1989. Induction by endoucleolytic DNA cleavage
in human actute myelogenous leukemia cells by etoposide,
camptothecin and other cytotoxic anticancer drugs: a
cautionary note. Cancer Res 48, 5870-5878.
79.Steller H. 1995. Mechanisms and genes of cellular suicide.
Science 267, 1445-1449.
80.Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, et al. 1997.
Prevention of apoptosis by Bcl-2: release of cytochrome c
from mitochondria blocked. Science 275, 1129-1132.
81.Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding
CK, et al. 1995. Identification and inhibition of the
ICE/CED-3 protease necessary for mammalian apoptosis.
Nature 376, 37-43.
82.Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, and
Earnshaw WC. 1994. Cleavage of poly(ADP-ribose) polymerase
by a proteinase with properties like ICE. Nature 371, 346-
347.
83.Tewari M, Quan LT, O''Rourke K, Desnoyers S, Zeng Z, et al.
1995. Yama/CPP32 beta, a mammalian homolog of CED-3, is a
CrmA-inhibitable protease that cleaves the death substrate
poly(ADP-ribose) polymerase. Cell 81, 801-809.
84.Green DR and Reed JC. 1998. Mitochondria and apoptosis.
Science 281, 1309-1312.
85.Adams JM and Cory S. 1998. The Bcl-2 protein family:
arbiters of cell survival. Science 281, 1322-1326.
86.Rao L and White E. 1997. Bcl-2 and the ICE family of
apoptotic regulators: makinga connection. Curr Opin Genet
Dev 7, 52-58.
87.Kawagishi H, Katsumi R, Sazawa T, Mizuno T, Hagiwara T, et
al. 1989.Cytotoxic steroids from the mushroom Agaricus
blazei. Phytochemistry 27, 2777-2779.
88.Mizuno M, Morimoto M, Minate K, and Tsuchida H. 1998.
Polysaccharides from Agaricus blazei stimulate lymphocyte T-
cell subsets in mice. Biosci Biotech Bioch 62, 434-437.
89.Song TY and Yen GC. 2002. Antioxidant properties of
Antrodia camphorata in submerged culture. J Agr Food Chem
50, 3322-3327.
90.Huang MT and Ferraro T: Phenolic compounds in food and
cancer prevention. In: Huang, MT, Ho CT, and Lee CY.
(Eds.).1992. Phenolic Compounds in Food and Health: II.
Antioxidants and Cancer Prevention. Am. Chem. Soc. Symp.
Ser., vol. 507, American Chemical Society, Washington, DC,
pp. 48-52.
91.Newmark HL: Plant phenolic compounds as inhibitors of
mutagenesis and carcinogenesis. In: Huang, MT, Ho CT, and
Lee CY. (Eds.). 1992. Phenolic Compounds in Food and
Health: II. Antioxidants and Cancer Prevention. Am. Chem.
Soc. Symp. Ser., vol. 507, American Chemical Society,
Washington, DC, pp. 48-52.
92.Liu F. Ooi VE. Chang ST. 1997. Free radical scavenging
activities of mushroom polysaccharide extracts. Life
Sciences. 60(10):763-71.
93.Zhu M. Gong Y. Yang Z. Ge G. Han C. Chen J. 1999. Green tea
and its major components ameliorate immune dysfunction in
mice bearing Lewis lung carcinoma and treated with the
carcinogen NNK. Nutrition & Cancer. 35(1):64-72.
94.Wasser SP. Weis AL. 1999. Therapeutic effects of substances
occurring in higher Basidiomycetes mushrooms: a modern
perspective. [Review] [220 refs] Critical Reviews in
Immunology. 19(1):65-96.
95.Mizuno, T.; Hagiwara, T,; Nakamura, T.; Ito, H.; Shimura,
K.; Sumiya, T.; Asakura, A. 1990. Antitumor activity and
some properties of water-soluble polysaccharides from
“Himematsutake”, the fruiting body of Agaricus blazei
murill. Agric. Biol. Chem. 54, 2889-2896.
96.Carr, Jacqueline H.; Bernadette, F. Rodak. 1999. Clinical
hematology atlas.Philadelphia : Saunders.
97.Henderson, L. M.; Chappel, J. B. 1996. NADPH oxidase of
neutrophils. Biochim. Biophys. Acta. 1273(2): 87-107
98.Alberts, B.; Bray, D.; Lewis, J.; Raff, M.; Roberts, K.;
Watson, J. D.1983. Mol. Biol. Cell. pp.918-924.
99.Edwards, S. W. 1994. in Biochemistry and physiology of the
neutrophil,Cambridge University Press, London.
100.Kakizuka, A.; Miller, W. H; Jr. Umesono, K. ; Warrell, R.
P; Jr.Frankel, S. R.;Murty, V. V.; Dmitrovsky, E.; Evans,
R. M. 1991.Chromosomal translocation t(15;17) in human
acute promyelocytic leukemia fuses RAR alpha with a novel
putative transcription factor,PML. Cell. 66(4): 663-674.
101.Landis, S. H.; Murray, T.; Bolden, S.; Wingo, P. A. 1998.
Cancer statistics, Ca: a Cancer Journal for Clinicians. 48
(1): 6-29.
102.Stone, R. M.; Mayer, R. J. 1993. Treatment of the newly
diagnosed adult with de novo acute myeloid leukemia.
Hematol. Oncol. Clin. N. Am. 7(1): 47-64.
103.Hoelzer, D. F. 1993. Therapy of the newly diagnosed adult
with acute lymphoblastic leukemia. Hematol. Oncol. Clin.
N.Am. 7(1): 139-160.
104.Kantarjian, H. M.; Smith, T. L.; O''Brien, S.; Beran, M.;
Pierce, S.; Talpaz, M. 1995. Prolonged survival in
chronic myelogenous leukemia after cytogenetic response to
interferon-alpha therapy. An. Intern. Med. 122(4): 254-261.
105.Faguet, G. B. 1994. Chronic lymphocytic leukemia: an
updated review. J. Clin. Oncol. 12(9): 1974-1990
106.Sherr CJ. 1996. Cancer cell cycles. Science. 274:1672-
1677.
107.Stephen IR. 1997. Fibronectin supports bronchial
epithelial cell adhesion and survival in the absence of
growth factor. The American Physiological society. L684-
L693.
108.Guido M, Isabelle J. 1995. Apoptosis, oncosis and
necrosis. American Society for Investigative Pathology.
146:3-15.
109.Hermann S. 1995. Mechanism and Genes of cellular suicide.
Science.267:1445-1448.
110.Dive C, Hickman JA. 1991. Drug-target interactions only
the first step in the commitment to a programmed cell
death？ British Journal of Cancer. 64:192-6.
111.Kerr JFR, wyllie AH, Currie AR. 1972. Apoptosis: a basic
biological phenomenon with wild ranging implications in
tissue kinetics. British Journal of Cancer. 26:1790-1794.
112.Zhang YH, Takahashi K, Jiang GZ, Kawai M, Fukada M,
Yokochi T. 1993.In vivo induction of apoptosis（programmed
cell death）in mouse thymus by administration of
lipopolysaccaride. Infection & Immunity. 61:5044-5048.
113.Martin SJ, Green DR. 1995. Apoptosis and cancer: the
failure of controls on cell death and cell survival.
Critical Reviews in Oncology/Hematology. 16:137-153.
114.Li N, Karin M. 1998. Ionizing radiation and short
wavelength UV activate NF-kappaB through two distinct
mechanisms. Proceedings of the National Academy of
Sciences of the United States of America. 95:13012-7.
115.Mastrangelo AJ, Betenbaugh MJ. 1998. Overcoming apoptosis:
new methods for improving protein-expression systems.
Trends in Biotechnology. 16:88-95.
116.Brown DG, Klrinr L, Tenniswood M. 1990. The biochemistry
of cell death by apoptosis. Biochem, Cell Biology. 88:1071-
1074.
117.Wylie AH, Kerr JF, Currie AR. 1980. Cell death: the
significance of apoptosis. International Review of
Cytology. 68:251-306.
118.McConkey DJ. 1998. Biochemical determinants of apoptosis
and necrosis. Toxicology Letters. 99:157-68.
119.Wyllie Andrew H. 1992. Apoptosis snd the regulation of
cell numbers in normal and neoplastic tissues : an
overview. Cancer and Metastasis Reviews. 11:95-103.
120.Nicholson DW, Thornberry NA. 1997. Caspases: killer
proteases. Trends in Biochemical Sciences. 22:299-306.
121.Widmann C, Johnson NL, Gardner AM, Smith RJ, Johnson GL.
1997. Potentiation of apoptosis by low dose stress stimuli
in cells expressing activated MEK hinase 1. Oncogene.
15:2439-47.
122.Cardone MH, Salvesen GS, Widmann C, Johnson G, Frisch SM.
1997. The regulstion of anoikis: MEKK-1 activation
requires cleavage by caspases. Cell. 90:315-23.
123.Green DR, Reed JC. 1998. Mitochondria and apoptosis.
Science.281:1309-12.
124.Nagata S, Golstein P. 1995.The Fas death factor.
Science.267:1449-56.
125.Wyllie A. 1997. Apoptosis. Clues in the p53 murder
mystery. Nature.389 :237-8.
126.Bates S, Vousden KH. 1996. p53 in signaling checlpoint
arrest or apoptosis.Current Opinion in Genetics &
Development. 6:12-8.
127.Zhan Q, Fan S, Bae I, Guillouf C. Liebermann DA. O’Connor
PM. Fornace AJ Jr. 1994. Induction of bax by genotoxic
stress in human cells correlates with normal p53 status
and apoptosis. Oncogene.9:3743-51.
128.Ellis RE, Yuan JY, Horvitz HR. 1991. Mechanisms and
functions of cell death. Annual Review of Cell Biology.
7:663-98.
129.Lin JK, Chou CK. 1992. In vitro apoptosis in the human
hepatoma cell line induced by transforming growth factor
beta 1. Cancer Research. 52:385-8.
130.Lowe SW, Schmitt EM, Smith SW. Osborne BA. Jacks T. 1993.
p53 is required for radiation-induced apoptosis in mouse
thymocytes. Nature.362:847-9.
131.Walton MI, Whysong D, O’Connor PM, Hockenbery D, Korseyer
SJ, Kohn KW. 1993. Constitutive expression of human Bcl-2
modulates nitrogen mustard and camptothecin induced
apoptosis. Cancer Research. 53:1853-61.
132.Kyprianou N, English HF, Davidson NE, Isaacs JT. 1991.
Programmed cell death during regression of the MCF-7
human breast cancer following estrogen ablation. Cancer
Research. 51:162-6.
133.Bertrand R, Solary E, Jenkins J, Pommier Y. 1993.
Apoptosis and its modulation in human promyelocytic HL-60
cells treated with DNA topoisomerase I and II
inhibitors.Experimental Cell Reseaech. 207:388-97.
134.Yoshioka A, Tanaka S, Hiraoka O, Koyama Y, Hirota Y,
Wataya Y. 1978. Deoxyribonucleoside-triphosphate imbalance
death: deoxyadenosine induced dNTP imbalance and DNA
double strand breaks in mouse FM3A cells and the
mechanism of cell death. Biochemical & Biophysical
Research Communications. 146:258-64.
135.Wagner BA, Buettner GR, Oberley LW, Darby CJ, Burns CP.
2000. Myeloperoxidase is involved in H2O2-induces
apoptosis of HL-60 human leukemia cells. Journal of
Biological Chemistry. 275:22461-9.
136.Flynn TP, Allen DW, Johnson GJ, White JG. 1983. Oxidant
damage of the lipids and proteins of the erythrocyte
membranes in unstable hameoglobin disease. The Journal of
Clinical Investigation. 71:1215-1223.
137.Tsujimoto, Y., Cossman, J., Jaffe, E. and Croce, C. M.
1985. Involvement of the Bcl-2 gene in human follicular
lymphoma. Science 228: 1440-3.
138.Oltvai, Z. N.; Milliman C. L. and Korsmeyer, S. J. 1993.
Bcl-2 heterodimerizes in vivo with a conserved homology,
Bax, that accelerates programmed cell death. Cell 74: 609-
19.
139.Hengartner, M. O. 2000. The biochemistry of apoptosis.
Nature 407: 770-6.
140.Toshiyuki, N.; Hong, Z.; Nobuhiro, M.; En, L.; Jin, X.;
Bruce, A. Y. and Junying, Y. 2000. Caspase-12 mediates
endoplasmic reticulum specific apoptosis and cytotoxicity
by amyloid —. Nature 403: 98-103.
141.Miller, D. K. 1997. The role of the caspase family of
cysteine proteases in apoptosis. Semin. Immunol. 9: 35-49.
142.Budihardjo, I.; Oliver, H.; Lutter, M.; Luo, X. and Wang,
X. 1999. Biochemical pathways of caspase activation during
apoptosis. Annu. Rev. Cell Dev. Biol. 15: 269-290.
143.Yoon, J. H. and Gores, G. J. 2002. Death receptor-mediated
apoptosis and the liver. J. Hepatology 37: 400-410.
144.Jaffe EA,Nachmam RL, Becker CD, Minick CR. 1973. Culture
of human endothelial cells derived from umbilical
veins.The Journal of Clinical Investigation. 52:2745-56.
145.Shen YH, Wang XL, Wilcken DE. 1998. Nitric oxide induces
and inhibits apoptosis through different pathways. FEBS
Letters. 433(1-2):125-31.
146.Gottlob K. Fulco M. Levrero M. Graessmann A. 1998 Dec 11.
The hepatitis B virus HBx protein inhibits caspase 3
activity. Journal of Biological Chemistry. 273(50):33347-
53.
147.Wyllie AH, Morris RG, Smith AL, Dunlop D. 1984. Chromatin
cleavage in apoptosis: association with condensed
chromatin morphology and dependence on macromolecular
synthesis. Journal of Pathology. 142: 67-77.
|